Skip to main content
. 2022 Jan 25;25(2):103806. doi: 10.1016/j.isci.2022.103806

Figure 3.

Figure 3

TRACEseq bioanalyzer validation from stable cell line

(A) Bioanalyzer analysis of large EVs mRNA content extracted from stable cell lines generated with the construct eGFP-C-YTHDF1/GPB1-CD9 (C1), eGFP-EIF4E-C-YTHDF1/GPB1-CD9 (4EC1) the negative control: GFP control, and the regular HEK 293T cells.

(B) Bioanalyzer analysis of cDNA generated from large EVs and their corresponding cDNA generated from cell lysates of the different stable cell lines (Same as above), triplicate of 10M cells per condition.